2 ageno w gallus as wittkowsky a crowther m hylek em

This preview shows page 64 - 66 out of 78 pages.

2. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2)(suppl):e44S-e88S. 3. Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: antithrombotic ther-apy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guide-lines. Chest. 2012;141(2)(suppl):e152S-e184S. 4. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos A-M, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: anti thrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines . Chest. 2012;141(2)(suppl):e691S-e736S. 5. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guide-lines. Chest. 2012;141(2)(suppl):e737S-e801S. 6. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians. Anti-thrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133(6 suppl):454S-545S. 7. Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23)(suppl 1):I-22-I30. 8. Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmo-nary embolism in patients with deep venous thrombosis: a systematic review. Am J Med. 2010;123(5):426-431. Downloaded From: by David Kinnison on 12/14/2012
CHEST / 141 / 2 / FEBRUARY, 2012 SUPPLEMENT e483S9. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmo-nary embolism. Thromb Haemost. 2002;88(3):407-414. 10. Baglin T, Douketis J, Tosetto A, et al. Does the clinical presentation and extent of venous thrombosis predict likeli-hood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost. 2010;8(11):2436-2442. 11. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279(6):458-462. 12. Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboem-bolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med. 2010;152(9):578-589. 13. Linkins L, O’Donnell M, Julian JA, Kearon C. Intracranial and fatal bleeding according to indication for long-term oral anticoagulant therapy. J Thromb Haemost. 2010;8(10):2201-2207. 14. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis . Ann Intern Med.

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture